ResMed | RMD - Selling And Administration Expenses


ResMed reported $285.65M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Ansell USD 274.8M 7.6M Dec/2025
Avita Medical AUD 19.03M 1.95M Dec/2025
Cochlear AUD 449.4M 214.45M Dec/2025
CSL USD 1.23B 498M Dec/2025
Fisher & Paykel Healthcare NZD 312.7M 27.2M Jun/2026
Healius AUD 393.4M 378.35M Dec/2024
Integral Diagnostics AUD 169.98M 18.73M Jun/2024
Mayne Pharma AUD 54.8M 11.94M Jun/2024
Nanosonics AUD 53.78M 26.93M Dec/2025
Polynovo AUD 17.04M 1.91M Dec/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
Regis Healthcare AUD 61.19M 6.96M Dec/2025
ResMed USD 285.65M 9.96M Mar/2026
Sigma Healthcare AUD 134.77M 9.73M Dec/2024
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Telix Pharmaceuticals AUD 107.02M 13.54M Jun/2026